{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:42:46Z","timestamp":1789620166834,"version":"build-2803163510"},"reference-count":51,"publisher":"Japanese Association of Rehabilitation Medicine","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PRM"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2490\/prm.20250003","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T22:12:08Z","timestamp":1737497528000},"page":"n\/a","source":"Crossref","is-referenced-by-count":1,"title":["Refractory Severe Anti-SRP Myopathy that Improved with Long-term Rehabilitation Therapy: A Case Report"],"prefix":"10.2490","volume":"10","author":[{"given":"Yumiko","family":"Nakao","sequence":"first","affiliation":[{"name":"Division of Rehabilitation Medicine, Gunma University Hospital, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ibe","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation Medicine, Gunma University Hospital, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Tazawa","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation Medicine, Gunma University Hospital, Maebashi, Japan"},{"name":"Department of Rehabilitation Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Arii","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation Medicine, Gunma University Hospital, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Toyama","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation Medicine, Gunma University Hospital, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Shirayoshi","sequence":"additional","affiliation":[{"name":"Department of Neurology, IMS Ohta Central General Hospital, Ohta, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Wada","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation Medicine, Gunma University Hospital, Maebashi, Japan"},{"name":"Department of Rehabilitation Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1338","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344\u2013347. PMID:1090839, DOI:10.1056\/NEJM197502132920706","DOI":"10.1056\/NEJM197502132920706"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working Group: 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord 2018;28:87\u201399. PMID:29221629, DOI:10.1016\/j.nmd.2017.09.016","DOI":"10.1016\/j.nmd.2017.09.016"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Ma X, Bu BT: Anti-SRP immune-mediated necrotizing myopathy: a critical review of current concepts. Front Immunol 2022;13:1019972. PMID:36311711, DOI:10.3389\/fimmu.2022.1019972","DOI":"10.3389\/fimmu.2022.1019972"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Ma X, Xu L, Ji S, Li Y, Bu B: The clinicopathological distinction between seropositive and seronegative immune-mediated necrotizing myopathy in China. Front Neurol 2021;12:670784. PMID:34290662, DOI:10.3389\/fneur.2021.670784","DOI":"10.3389\/fneur.2021.670784"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Suzuki S, Nishikawa A, Kuwana M, Nishimura H, Watanabe Y, Nakahara J, Hayashi YK, Suzuki N, Nishino I: Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients. Orphanet J Rare Dis 2015;10:61. PMID:25963141, DOI:10.1186\/s13023-015-0277-y","DOI":"10.1186\/s13023-015-0277-y"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Wang L, Liu L, Hao H, Gao F, Liu X, Wang Z, Zhang W, Lv H, Yuan Y: Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients. Neuromuscul Disord 2014;24:335\u2013341. PMID:24491486, DOI:10.1016\/j.nmd.2014.01.002","DOI":"10.1016\/j.nmd.2014.01.002"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I: Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry 2016;87:1038\u20131044. PMID:27147697, DOI:10.1136\/jnnp-2016-313166","DOI":"10.1136\/jnnp-2016-313166"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Suzuki S, Hayashi YK, Kuwana M, Tsuburaya R, Suzuki N, Nishino I: Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome. Arch Neurol 2012;69:728\u2013732. PMID:22332183, DOI:10.1001\/archneurol.2011.1728","DOI":"10.1001\/archneurol.2011.1728"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Khan T, Shareef A, Shahid M, Shabbir E, Musleh M: A rare case of PL-7-associated immune-mediated necrotizing myopathy with isolated dysphagia as the presenting symptom. Cureus 2023;15:e37215. PMID:37159795, DOI:10.7759\/cureus.37215","DOI":"10.7759\/cureus.37215"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Chen N, Thein KY, Tay SS: Inpatient rehabilitation and functional outcome of a case of anti-SRP immune mediated necrotising myopathy. J Rehabil Med Clin Commun 2024;7:jrmcc40653. PMID:39444782, DOI:10.2340\/jrm-cc.v7.40653","DOI":"10.2340\/jrm-cc.v7.40653"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV: Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 2004;50:209\u2013215. PMID:14730618, DOI:10.1002\/art.11484","DOI":"10.1002\/art.11484"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Brouwer R, Hengstman GJ, Egberts WV, Ehrfeld H, Bozic B, Ghirardello A, Gr\u00f8ndal G, Hietarinta M, Isenberg D, Kalden JR, Lundberg I, Moutsopoulos H, Roux-Lombard P, Vencovsky J, Wikman A, Seelig HP, van Engelen BG, van Venrooij WJ: Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001;60:116\u2013123. PMID:11156543, DOI:10.1136\/ard.60.2.116","DOI":"10.1136\/ard.60.2.116"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Halic M, Becker T, Pool MR, Spahn CM, Grassucci RA, Frank J, Beckmann R: Structure of the signal recognition particle interacting with the elongation-arrested ribosome. Nature 2004;427:808\u2013814. PMID:14985753, DOI:10.1038\/nature02342","DOI":"10.1038\/nature02342"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Arouche-Delaperche L, Allenbach Y, Amelin D, Preusse C, Mouly V, Mauhin W, Tchoupou GD, Drouot L, Boyer O, Stenzel W, Butler-Browne G, Benveniste O: Pathogenic role of anti-signal recognition protein and anti-3\u2010hydroxy\u20103\u2010methylglutaryl\u2010CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Ann Neurol 2017;81:538\u2013548. PMID:28224701, DOI:10.1002\/ana.24902","DOI":"10.1002\/ana.24902"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Werner JL, Christopher-Stine L, Ghazarian SR, Pak KS, Kus JE, Daya NR, Lloyd TE, Mammen AL: Antibody levels correlate with creatine kinase levels and strength in anti-3\u2010hydroxy\u20103\u2010methylglutaryl\u2010coenzyme A reductase-associated autoimmune myopathy. Arthritis Rheum 2012;64:4087\u20134093. PMID:22933019, DOI:10.1002\/art.34673","DOI":"10.1002\/art.34673"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BG: Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 2006;65:1635\u20131638. PMID:16679430, DOI:10.1136\/ard.2006.052191","DOI":"10.1136\/ard.2006.052191"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Jones DA, Newham DJ, Round JM, Tolfree SE: Experimental human muscle damage: morphological changes in relation to other indices of damage. J Physiol 1986;375:435\u2013448. PMID:3025428, DOI:10.1113\/jphysiol.1986.sp016126","DOI":"10.1113\/jphysiol.1986.sp016126"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Alexanderson H: Exercise effects in patients with adult idiopathic inflammatory myopathies. Curr Opin Rheumatol 2009;21:158\u2013163. PMID:19339927, DOI:10.1097\/BOR.0b013e328324e700","DOI":"10.1097\/BOR.0b013e328324e700"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Habers GE, Takken T: Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy\u2014a systematic review. Rheumatology (Oxford) 2011;50:2113\u20132124. PMID:21890619, DOI:10.1093\/rheumatology\/ker292","DOI":"10.1093\/rheumatology\/ker292"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Alexanderson H: Physical exercise as a treatment for adult and juvenile myositis. J Intern Med 2016;280:75\u201396. PMID:26854121, DOI:10.1111\/joim.12481","DOI":"10.1111\/joim.12481"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Van Thillo A, Vulsteke JB, Van Assche D, Verschueren P, De Langhe E: Physical therapy in adult inflammatory myopathy patients: a systematic review. Clin Rheumatol 2019;38:2039\u20132051. PMID:31115788, DOI:10.1007\/s10067-019-04571-9","DOI":"10.1007\/s10067-019-04571-9"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Alexanderson H: Exercise in myositis. Curr Treatm Opt Rheumatol 2018;4:289\u2013298. PMID:30613464, DOI:10.1007\/s40674-018-0113-3","DOI":"10.1007\/s40674-018-0113-3"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Zeng R, Schmidt J: Impact and management of dysphagia in inflammatory myopathies. Curr Rheumatol Rep 2020;22:74. PMID:32860119, DOI:10.1007\/s11926-020-00950-3","DOI":"10.1007\/s11926-020-00950-3"},{"key":"24","unstructured":"24. Oohata S, Mugii N, Hamaguchi Y, Someya F: Rehabilitation and clinical features of myopathies in Japanese patients with anti-signal recognition particle (SRP) antibody: three case studies [in Japanese]. Sogo Rehabil 2017;45:53\u201357."},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Niino R, Nikaido Y, Urakami H, Ishida N: Exercise intensity based on the skeletal muscle quality and physiological cost index of patients with immune-mediated necrotizing myopathy: a case report [in Japanese]. Rigaku Ryoho Kagaku 2023;38:466\u2013471. DOI:10.1589\/rika.38.466","DOI":"10.1589\/rika.38.466"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL: A penetration-aspiration scale. Dysphagia 1996;11:93\u201398. PMID:8721066, DOI:10.1007\/BF00417897","DOI":"10.1007\/BF00417897"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Alexanderson H, Dastmalchi M, Esbj\u00f6rnsson-Liljedahl M, Opava CH, Lundberg IE: Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Care Res 2007;57:768\u2013777. PMID:17530676, DOI:10.1002\/art.22780","DOI":"10.1002\/art.22780"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Mattar MA, Gualano B, Roschel H, Perandini LA, Dassouki T, Lima FR, Shinjo SK, de S\u00e1 Pinto AL: Exercise as an adjuvant treatment in persistent active polymyositis. J Clin Rheumatol 2014;20:11\u201315. PMID:24356483, DOI:10.1097\/RHU.0000000000000056","DOI":"10.1097\/RHU.0000000000000056"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Dastmalchi M, Alexanderson H, Loell I, St\u00e5hlberg M, Borg K, Lundberg IE, Esbj\u00f6rnsson M: Effect of physical training on the proportion of slow\u2010twitch type I muscle fibers, a novel nonimmune\u2010mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Care Res 2007;57:1303\u20131310. PMID:17907213, DOI:10.1002\/art.22996","DOI":"10.1002\/art.22996"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Cardoso R, Parola V, Neves H, Bernardes RA, Duque FM, Mendes CA, Pimentel M, Caetano P, Petronilho F, Albuquerque C, Sousa LB, Mal\u00e7a C, Dur\u00e3es R, Xavier W, Parreira P, Ap\u00f3stolo J, Cruz A: Physical rehabilitation programs for bedridden patients with prolonged immobility: a scoping review. Int J Environ Res Public Health 2022;19:6420. PMID:35682005, DOI:10.3390\/ijerph19116420","DOI":"10.3390\/ijerph19116420"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Campos A, Cort\u00e9s E, Martins D, Ferre M, Contreras A: Development of a flexible rehabilitation system for bedridden patients. J Braz Soc Mech Sci Eng 2021;43:361. DOI:10.1007\/s40430-021-03073-7","DOI":"10.1007\/s40430-021-03073-7"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Arias-Fern\u00e1ndez P, Romero-Martin M, G\u00f3mez-Salgado J, Fern\u00e1ndez-Garc\u00eda D: Rehabilitation and early mobilization in the critical patient: systematic review. J Phys Ther Sci 2018;30:1193\u20131201. PMID:30214124, DOI:10.1589\/jpts.30.1193","DOI":"10.1589\/jpts.30.1193"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Datta Gupta A, Quadros N: Intensive rehabilitation in a patient with inclusion body myositis. Med J Aust 2009;190:208\u2013209. PMID:19220189, DOI:10.5694\/j.1326-5377.2009.tb02352.x","DOI":"10.5694\/j.1326-5377.2009.tb02352.x"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, Maisonobe T, Dubourg O, Behin A, Laforet P, Stojkovic T, Eymard B, Costedoat-Chalumeau N, Campana-Salort E, Tournadre A, Musset L, Bader-Meunier B, Kone-Paut I, Sibilia J, Servais L, Fain O, Larroche C, Diot E, Terrier B, De Paz R, Dossier A, Menard D, Morati C, Roux M, Ferrer X, Martinet J, Besnard S, Bellance R, Cacoub P, Arnaud L, Grosbois B, Herson S, Boyer O, Benveniste O, French Myositis Network: Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore) 2014;93:150\u2013157. PMID:24797170, DOI:10.1097\/MD.0000000000000028","DOI":"10.1097\/MD.0000000000000028"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O: Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum 2011;63:1961\u20131971. PMID:21400483, DOI:10.1002\/art.30344","DOI":"10.1002\/art.30344"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Corrado B, Ciardi G, Lucignano L: Supervised physical therapy and polymyositis\/dermatomyositis\u2014a systematic review of the literature. Neurol Int 2020;12:77\u201388. PMID:33255200, DOI:10.3390\/neurolint12030015","DOI":"10.3390\/neurolint12030015"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Stathopoulos P, Dalakas MC: Autoimmune neurogenic dysphagia. Dysphagia 2022;37:473\u2013487. PMID:34226958, DOI:10.1007\/s00455-021-10338-9","DOI":"10.1007\/s00455-021-10338-9"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Knigge MA, Thibeault S, McCulloch TM: Implementation of high-resolution manometry in the clinical practice of speech language pathology. Dysphagia 2014;29:2\u201316. PMID:24233810, DOI:10.1007\/s00455-013-9494-5","DOI":"10.1007\/s00455-013-9494-5"},{"key":"39","unstructured":"39. Carlson DA, Pandolfino JE: High-resolution manometry in clinical practice. Gastroenterol Hepatol (N Y) 2015;11:374\u2013384. PMID:27118931"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Labeit B, Pawlitzki M, Ruck T, Muhle P, Claus I, Suntrup-Krueger S, Warnecke T, Meuth SG, Wiendl H, Dziewas R: The impact of dysphagia in myositis: a systematic review and meta-analysis. J Clin Med 2020;9:2150. PMID:32650400, DOI:10.3390\/jcm9072150","DOI":"10.3390\/jcm9072150"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Kelly JH: Management of upper esophageal sphincter disorders: indications and complications of myotomy. Am J Med 2000;108:43\u201346. PMID:10718451, DOI:10.1016\/S0002-9343(99)00334-4","DOI":"10.1016\/S0002-9343(99)00334-4"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Langdon PC, Mulcahy K, Shepherd KL, Low VH, Mastaglia FL: Pharyngeal dysphagia in inflammatory muscle diseases resulting from impaired suprahyoid musculature. Dysphagia 2012;27:408\u2013417. PMID:22207246, DOI:10.1007\/s00455-011-9384-7","DOI":"10.1007\/s00455-011-9384-7"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Azola A, Mulheren R, McKeon G, Lloyd T, Christopher-Stine L, Palmer J, Chung TH: Dysphagia in myositis: a study of the structural and physiologic changes resulting in disordered swallowing. Am J Phys Med Rehabil 2020;99:404\u2013408. PMID:31764229, DOI:10.1097\/PHM.0000000000001354","DOI":"10.1097\/PHM.0000000000001354"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Argov Z, de Visser M: Dysphagia in adult myopathies. Neuromuscul Disord 2021;31:5\u201320. PMID:33334661, DOI:10.1016\/j.nmd.2020.11.001","DOI":"10.1016\/j.nmd.2020.11.001"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Malandraki GA, Kaufman A, Hind J, Ennis S, Gangnon R, Waclawik A, Robbins J: The effects of lingual intervention in a patient with inclusion body myositis and Sj\u00f6gren\u2019s syndrome: a longitudinal case study. Arch Phys Med Rehabil 2012;93:1469\u20131475. PMID:22480545, DOI:10.1016\/j.apmr.2012.02.010","DOI":"10.1016\/j.apmr.2012.02.010"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Greenberg SA: Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 2007;69:2008\u20132019. PMID:17928577, DOI:10.1212\/01.WNL.0000291619.17160.b8","DOI":"10.1212\/01.WNL.0000291619.17160.b8"},{"key":"47","doi-asserted-by":"publisher","unstructured":"47. Preu\u00dfe C, Goebel HH, Held J, Wengert O, Scheibe F, Irlbacher K, Koch A, Heppner FL, Stenzel W: Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile. Am J Pathol 2012;181:2161\u20132171. PMID:23058368, DOI:10.1016\/j.ajpath.2012.08.033","DOI":"10.1016\/j.ajpath.2012.08.033"},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L: Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res (Hoboken) 2010;62:1328\u20131334. PMID:20506493, DOI:10.1002\/acr.20219","DOI":"10.1002\/acr.20219"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49. Zhang W, Prince HM, Reardon K: Statin-induced anti-HMGCR antibody-related immune-mediated necrotising myositis achieving complete remission with rituximab. BMJ Case Rep 2019;12:e232406. PMID:31791994, DOI:10.1136\/bcr-2019-232406","DOI":"10.1136\/bcr-2019-232406"},{"key":"50","doi-asserted-by":"publisher","unstructured":"50. Xiong A, Yang G, Song Z, Xiong C, Liu D, Shuai Y, He L, Zhang L, Guo Z, Shuai S: Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series. Ther Adv Neurol Disord 2021;14:1756286421998918. PMID:33786066, DOI:10.1177\/1756286421998918","DOI":"10.1177\/1756286421998918"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51. Gupta S, Rakhra A, Thallapally V, Nahas J: Rituximab use for refractory anti-HMGCR immune-mediated necrotizing myopathy: a case report. Intractable Rare Dis Res 2021;10:122\u2013125. PMID:33996358, DOI:10.5582\/irdr.2020.03144","DOI":"10.5582\/irdr.2020.03144"}],"container-title":["Progress in Rehabilitation Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/prm\/10\/0\/10_20250003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:04:31Z","timestamp":1737777871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/prm\/10\/0\/10_20250003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":51,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2490\/prm.20250003","relation":{},"ISSN":["2432-1354"],"issn-type":[{"value":"2432-1354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"20250003"}}